interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Drug shortage outlook › Atropine Sulfate

Shortage outlook · all drugs · read October 2026

How long has Atropine Sulfate been on the FDA shortage list?

Atropine Sulfate has been on the FDA shortage list for 12 years and 5 months. 0 of the 397 listings measured since 2014 lasted at least that long. Only 0 past listings reached this age, too few to show a share. The counts are below. These are counts of listings, not a forecast.

Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.
Atropine Sulfateon the FDA shortage list now
149months listed

Atropine Sulfate has been on the FDA shortage list for 12 years and 5 months (June 2014 to October 2026).

  1. 0 of the 397 listings measured since 2014 lasted at least that long.
  2. Only 0 past listings reached this age, too few to show a share. The counts are below.
  3. None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.

The listing history, to scale

  1. Atropine Sulfate InjectionListed since June 2014 · 12 years and 5 months · already listed when the archive began

What past listings of this age did

Of past listings that had already run 12 years and 5 months, how many were still listed later?

After 6 more monthsno past listing lasted this long0 listings measured
After 12 more monthsno past listing lasted this long0 listings measured
After 24 more monthsno past listing lasted this long0 listings measured

What the FDA list says about it today

17presentations listed
8companies
1 January 2012first posted

Reasons companies gave: requirements related to complying with good manufacturing practices (3), other (2) and discontinuation of the manufacture of the drug (2); 10 of 17 gave none. FDA category: Anesthesia; Neurology; Pediatric.

Company by company

Of 17 presentations, the companies reported 10 available, 1 with limited availability and 6 unavailable. This is each company's own report to the FDA, with the date of its last update.

FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.

Where can you go from this result?

This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.

To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.